Seller record · Telehealth service
VirtualCare2Go
Fails 2 of 8 criteria. S4, compounding disclosure: The weight loss page sells a compounded semaglutide tier with no statement that compounded drugs are not FDA-approved, and neither the answers nor the terms carry one. 1 more criterion also fails; see the table below.
At a glance
VirtualCare2GoTelehealth service
- Price
- Compounded semaglutide $279 for one month, brand injections $629
- Sells
- semaglutide, liraglutide or tirzepatide injections, semaglutide tablets, and 3 more
- FDA letters
- None on file
Telehealth service. Passes 5 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.
A Texas telehealth service for urgent and primary care that also sells one-month GLP-1 weight loss tiers, brand semaglutide, liraglutide or tirzepatide injections, semaglutide tablets and compounded semaglutide, each with a video consultation included. It names its partner pharmacy, and the compounded tier carries no statement that it is not FDA-approved.
Operating entity No legal entity name appears in the footer, on the contact page, in the terms of use or in the privacy policy; the home page names only an outside billing company.
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | VirtualCare2Go's weight loss page; VirtualCare2Go's FAQ; VirtualCare2Go's website |
| S2 | Prescription gating | NOT VERIFIED | VirtualCare2Go's weight loss page; VirtualCare2Go's FAQ; VirtualCare2Go's privacy policy |
| S3 | Pharmacy identification | PASS | VirtualCare2Go's contact page |
| S4 | Compounding disclosure | FAIL | VirtualCare2Go's weight loss page; VirtualCare2Go's FAQ; VirtualCare2Go's terms of use page |
| S5 | Analytical documentation | FAIL | VirtualCare2Go's weight loss page; VirtualCare2Go's terms of use page |
| S6 | Business address | PASS | VirtualCare2Go's contact page; VirtualCare2Go's terms of use page |
| S7 | Price disclosure | PASS | VirtualCare2Go's weight loss page; VirtualCare2Go's selfpay page |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: semaglutide, liraglutide or tirzepatide injections, semaglutide tablets, compounded semaglutide, weight loss consultation, urgent care.
Other sellers of the same products
Who sells semaglutideWho sells tirzepatideWho sells liraglutide
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.